ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "race/ethnicity"

  • Abstract Number: 1850 • ACR Convergence 2025

    First American SLE patients demonstrate enhanced lipid metabolism and B cell activation by high-content proteomic analyses

    Rufei Lu1, Tayte Stephens2, Carla Guthridge1, Miles Smith1, Joseph Kheir1, Cristina Arriens1, Joan Merrill3, Marci Beel4, Susan Macwana1, Wade DeJager5, Nicholas Domingez1, Teresa Aberle1, Joel Guthridge1 and Judith James1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2University of Oklahoma Health Science Center, Oklahoma City, OK, 3Oklahoma Medical Research Foundation, Oklahoma City 73104, OK, 4Oklahoma Medical Research Foun, Oklahoma City, OK, 5Oklahoma Medical Research Foundation, Oklahoma City

    Background/Purpose: Systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) are autoimmune diseases with overlapping yet distinct immunopathologies. Proteomic profiling of soluble plasma factors can reveal…
  • Abstract Number: 1061 • ACR Convergence 2025

    Screening for Hepatitis B in a Veterans Health Administration Subpopulation with Rheumatological Disease Prior to Initiating Immunosuppressive Therapy: a retrospective study on testing and treatment within the Black American population from the VAMC in Memphis, TN

    Daniel Austin1, Beenish Zulfiqar2, Akhil Adla1, Jeffrey Zuber2 and Joshua Sullivan3, 1University of Tennessee Health Science Center, Memphis, TN, 2University of Tennessee Health Science Center & Lt. Col. Luke J. Weathers, Jr. VA Medical Center, Memphis, TN, Memphis, TN, 3Lt. Col. Luke J. Weathers, Jr. VA Medical Center, Memphis, TN, Memphis, TN

    Background/Purpose: Hepatitis B virus (HBV) screening is insufficiently completed prior to initiation of immunosuppressive therapy nationwide. Various factors including alert fatigue, provider mistakes, non-compliance, and…
  • Abstract Number: 1795 • ACR Convergence 2025

    Trends and Disparities in Osteoarthritis-Related Mortality in the United States: A 21-Year Analysis (1999-2020)

    muzamil Khan1, Swetha Balaji2, Ayesha Cheema3, Wajdan Ahmad3, Dhruv gandhi4 and Steven Golombek5, 1George Washington University School of Medicine and Health Sciences, Washington D.C, 2New York Medical College at St. Mary's General Hospital and St. Clare's Health, Parsippany-Troy Hills, NJ, 3Al Tibri Medical College, Karachi, Pakistan, 4St. Francis Medical Center, Monroe, 5NYMC at St. Mary's General Hospital and St. Clare's Health, Dover

    Background/Purpose: Osteoarthritis/arthrosis is an aging-related disease which is associated with significant morbidity in the United States. However, epidemiological data regarding osteoarthritis-associated mortality in the United…
  • Abstract Number: 1012 • ACR Convergence 2025

    Racial and Gender Disparities in Gout Clinical Trials

    Fizza Zulfiqar1, Dania Kaur2, Meaghan Bethea3, Taylor Spencer4, Samhitha Bitla5, Abhinav Vyas6 and Camelia Arsene7, 1Trinity Health Oakland/Wayne State University, Pontiac, MI, 2North Alabama Medical Center, Muscle Shoals, AL, 3Trinity Health Oakland Hopsital, Pontiac, MI, 4Trinity Health Oaklnd Hospital, Pontiac, MI, 5Trinity Health Oakland Hospital, Pontiac, MI, 6Vanderbilt University, Nashvile, TN, 7Trinity Health Oakland Hospital, Pontiac

    Background/Purpose: To develop effective novel treatment strategies for Gout disease that cater to patients from diverse backgrounds, it is crucial that all racial groups, without…
  • Abstract Number: 1707 • ACR Convergence 2025

    Racial and Ethnic Disparities in Kidney Transplant Outcomes Among Patients With Systemic Lupus Erythematosus (SLE): A 20-Year Analysis Spanning Before and After the 2014 Kidney Allocation System Revision

    Soziema Salia1, Boniface Mensah2, Ufuoma Mamoh1, Gilava Hedayati1, Terrylyna Baffoe-Bonnie3, Joan Morny4 and Christhopher Haas3, 1MedStar Health Georgetown University (Baltimore) Internal Medicine Program, Baltimore, MD, 2MedStar Health Georgetown University (Baltimore) Internal Medicine Program, Baltimore, CA, 3MedStar Health Georgetown University (Baltimore) Internal Medicine Program, Baltimore, 4Piedmont Athens Regional Internal Medicine Residency Program, Athens, GA

    Background/Purpose: Systemic lupus erythematosus (SLE) is a leading cause of end-stage kidney disease (ESKD) in young women, particularly among racial and ethnic minorities. Kidney transplantation…
  • Abstract Number: 0841 • ACR Convergence 2025

    Comparing the Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Outcomes in Lupus Nephritis: A Retrospective Cohort Study

    Kinga Grzybowski1 and Irene Tan2, 1Jefferson Einstein Montgomery Hospital, Maspeth, NY, 2Einstein Healthcare Network Philadelphia - Jefferson Health, Bala Cynwyd, PA

    Background/Purpose: Lupus Nephritis (LN) is one of the most serious complications of SLE (Systemic Lupus Erythematosus) characterized by an attack of the kidneys by the…
  • Abstract Number: 1513 • ACR Convergence 2025

    Race, Renal Failure, and Risk: A five-to-ten year retrospective cohort study of Racial differences in outcomes of patients with dialysis-dependent Lupus nephritis

    Ufuoma Mamoh1, Queeneth Edwards2, Chukwuemelie Okeke3, Justin Riley Lam4, Soziema Salia5 and Christhopher Haas6, 1Medstar Health Georgetown University Internal Medicine Residency Program, Baltimore, MD, 2Georgia Southern University, Statesboro, GA, 3Maimonides Medical Center, Brooklyn, NY, 4Albert Einstein Medical Center, Philadelphia, PA, 5MedStar Health Georgetown University (Baltimore) Internal Medicine Program, Baltimore, MD, 6MedStar Health Georgetown University (Baltimore) Internal Medicine Program, Baltimore

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that disproportionately affects racial and ethnic minority populations, particularly Black/African American and Hispanic/Latino individuals. In…
  • Abstract Number: 0785 • ACR Convergence 2025

    It Takes a Community: Exploring the Importance of Community-Level Social Determinants of Health in Total Knee Arthroplasty Outcomes

    Chloe Heiting1, Yiyuan Wu2, Susan Goodman3, Peter Sculco4, Fei Wang2, Rich Caruana5, Peter Cram6, Said Ibrahim7 and Bella Mehta8, 1Northwell Health, New Hyde Park, NY, 2Weill Cornell Medicine, New York, NY, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 4Hospital for Special Surgery, New York, NY, 5Microsoft, Redmond, WA, 6University of Maryland School of Medicine, Baltimore, MD, 7Thomas Jefferson University, Philadelphia, PA, 8Hospital for Special Surgery, Weill Cornell Medicine, Jersey City, NJ

    Background/Purpose: Despite changing trends and increased utilization of total knee arthroplasty (TKA) in the United States,1 there are still prominent racial and ethnic disparities in…
  • Abstract Number: 1348 • ACR Convergence 2025

    Real World Evaluation on the Effectiveness of Baricitinib or Other Treatments in Patients With Rheumatoid Arthritis: Data from the European and Non-European Cohorts of the RA-BE-REAL Study

    Rieke Alten1, Gerd Burmester2, Marco Matucci-Cerinic3, Jens Gerwien4, Walid Fakhouri4, Samuel Ogwu4, Ewa Haladyj4, Inmaculada De La Torre4, Bruno Fautrel5 and AJ Fernandez4, 1SCHLOSSPARK KLINK, Teaching Hospital of University Medicine Berlin, Department of Internal Medicine and Rheumatology, Berlin, Germany, 2Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany, 3University San Raffaele Milano, Milano, Milan, Italy, 4Eli Lilly and Company, Indiana Polis, IN, 5Sorbonne Université - APHP, Department of Rheumatology, Hôpital Pitié-Salpêtrière, Inserm UMRS 1136-5, PARIS, France, Paris, France

    Background/Purpose: Here, we provide descriptive baseline characteristics and effectiveness outcomes of Baricitinib (BARI) and other ts/bDMARDs at 24-month (24M) in both European (EU) and non-European…
  • Abstract Number: 0741 • ACR Convergence 2025

    Characteristics of African American vs. Non-African American Patients with Giant Cell Arteritis: A Retrospective Cohort Study

    Dana Nachawati1, Milad Heydari-Kamjani2, Keri Ann Pfeil1, Elleson Harper1, Meghan Gump1, Lindsay Frumker1, Ansaam Daoud3 and Omer Pamuk2, 1University Hospitals Cleveland Medical Center/Case Western Reserve University, Cleveland, OH, 2University Hospitals Cleveland Medical Center/ Case Western Reserve University, Cleveland, OH, 3Case Western Reserve University/University Hospitals, Cleveland, OH

    Background/Purpose: GCA is a vasculitis of large and medium-sized arteries that has been well-studied in populations of European descent; however, data on African American (AA)…
  • Abstract Number: 1270 • ACR Convergence 2025

    Increasing Participation in the FT819 Cell Therapy Trial Amongst People Living with Lupus: A Focus Group Study

    Joy Buie1, Safoah Agyemang1, Andrew Henry2, Andrew BitMansour3, Vaneet Sandhu4, Debra Zack5 and Michael Fisher1, 1Lupus Foundation of America, Washington, DC, 2Fate Therapeutics, Inc., San Diego, CA, 3Fate Therapeutics, Inc., San Carlos, CA, 4Fate Therapeutics, Inc., San Diego, 5Fate Therapeutics, San Diego

    Background/Purpose: Clinical trials exploring the safety and efficacy of chimeric antigen receptor (CAR) T-cell therapy for lupus are growing. Challenges linked to recruitment for CAR…
  • Abstract Number: 0742 • ACR Convergence 2025

    Exploring Racial Variation in the Clinical Manifestations of Giant Cell Arteritis: A Retrospective Single-Center Study

    Dana Nachawati1, Chelsea Guan1, Amir Daneshvar1, Ansaam Daoud2 and Omer Pamuk3, 1University Hospitals Cleveland Medical Center/Case Western Reserve University, Cleveland, OH, 2Case Western Reserve University/University Hospitals, Cleveland, OH, 3University Hospitals Cleveland Medical Center/ Case Western Reserve University, Cleveland, OH

    Background/Purpose: Giant cell arteritis (GCA) is a large and medium vessel vasculitis affecting older adults of Northern European descent. While GCA is well characterized in…
  • Abstract Number: 1224 • ACR Convergence 2025

    Comparative Effectiveness of Duloxetine versus Pregabalin in Fibromyalgia: A Large-Scale, Real-World Study Across 300,000 Patients

    Chukwuemelie Okeke1, Queeneth Edwards2, Ufuoma Mamoh3, Justin Riley Lam4 and Chekwubejah Uwakwe5, 1Maimonides Medical Center, Brooklyn, NY, 2Department of Epidemiology and Biostatistics, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, GA, 3Medstar Health Georgetown University Internal Medicine Residency Program, Baltimore, MD, 4Jefferson Einstein Hospital, Philadelphia, PA, 5Nnamdi Azikiwe University Teaching Hospital, Nigeria, Nnewi, Anambra, Nigeria

    Background/Purpose: Fibromyalgia (FM) is a chronic, debilitating condition characterized by widespread pain, fatigue, and cognitive disturbances. Despite the availability of FDA-approved treatments, real-world comparative effectiveness…
  • Abstract Number: 0392 • ACR Convergence 2025

    Clinical Indicators of Methotrexate Response in Juvenile Idiopathic Arthritis (JIA) and JIA with Uveitis (JIA-U)

    Abigale Jagger1, Mara Becker2, Susan Thompson3, Mekibib Altaye4, John Bohnsack5, Hermine Brunner6, Margaret Chang7, Ashley Cooper8, Stefanie Davidson9, Alexandra Duell6, Bharti Gangwani7, Carl Langefeld10, Melissa Lerman11, Mindy Lo7, Serena Pastore12, Mariia Pavlenko13, Sampath Prahalad14, Megan Quinlan-Waters15, Laura Ramsey16, Grant Schulert6, Gabriele Simonini17, Erin Stahl8, Gabriele Stocco18, Marc Sudman19, Andrea Taddio18, Virginia Miraldi Utz6, Rae Yeung20 and Sheila Angeles-Han1, 1Cincinnati Children's Hospital, Cincinnati, OH, 2Duke University Medical Center/Duke Clinical Research Institute, Chapel Hill, NC, 3Cincinnati Children's Hospital Medical Center/Univ of Cincinnati College of Medicine, BLUE ASH, OH, 4Cincinnati Children's Hospital, Cincinnati, 5University of Utah, Salt Lake City, UT, 6Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 7Boston Children's Hospital, Boston, MA, 8Children's Mercy Kansas City, Kansas City, MO, 9University of Pennsylvania/CHOP, Philadelphia, PA, 10Wake Forest University School of Medicine, Winston Salem, NC, 11Children's Hospital of Philadelphia, Philadelphia, PA, 12Institute of Child and Maternal Health - IRCCS "Burlo Garofolo", Trieste, Italy, 13Cincinnati Children`s Hospital Medical Center, Cincinnati, OH, 14Emory + Children's Pediatric Institute, Atlanta, GA, 15Cincinnati Children's Hospital Medical Center, CCHMC, 16Children's Mercy, Kansas City, MO, 17Rheumatology Unit, ERN-ReCONNET center, Meyer Children's Hospital IRCCS, Firenze, Firenze, Italy, 18Insitute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy, 19Cincinnati Children's Hospital Medical Center, Cincinnati, 20The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Patients with JIA are at high risk for development of chronic anterior uveitis (CAU), impacting 10-20% of this population. Although methotrexate (MTX) is the…
  • Abstract Number: 2230 • ACR Convergence 2025

    Racial and Ethnic Disparities in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Their Impact on Antifibrotic Therapy

    Andrea Galecio Chao, Baylor College of Medicine, Houston, TX

    Background/Purpose: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a significant cause of morbidity and mortality among patients with rheumatoid arthritis (RA), often leading to progressive…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 16
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology